To assess the antitumor vaccination potential of dying cancer cells exposed to MTX or MTX + KIRA6 (KIRA6 in the absence of MTX, did not induce cell death) we then injected CT26 stressed/dying cells subcutaneously in the flank of immunocompetent mice. The gene discussed is DDX53; the disease is cancer.